Kevin Muir
GM INTERVENTIONAL ONCOLOGY · DELCATH SYSTEMS, INC.
Individual
- 2026
- Feb 19, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kevin Muir files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Gerard J. Michel - $198K in DCTH purchases and sales in the last 12 months
- Sandra Pennell - $50K in DCTH purchases and sales in the last 12 months
- John Richard Sylvester - $39K in DCTH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kevin Muir?
Kevin Muir is a corporate insider, tracked as GM INTERVENTIONAL ONCOLOGY of DELCATH SYSTEMS, INC. (DCTH). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Kevin Muir last file a Form 4?
The only primary Form 4 on record is dated 19 February 2026.